history of tirzepatide glucagon-like peptide-1 receptor agonists The development and use of

Effect of propionyl-L-carnitine in the treatment of diabetic angiopathy: controlled double blind trial versus placebo

If youve ever been told things like they just need more discipline or theyll grow out of it, this episode is for you

Key findings Related Stories Chinese researchers map epigenetic control of congenital heart defects Spermidine boosts key cellular processes linked to aging in early research High doses of caffeine from energy drinks cause cardiovascular harm Within six months of starting GLP-1 therapy, the rate of hypotensive events increased from 8.7% to 10.2% The increased risk remained significant at 12 months, with hypotensive events rising from 13.6% to 14.3% Adults age 65 and older accounted for 53% of hypotensive events despite representing 37% of the study population Patients with Type 2 diabetes made up 75% of those experiencing hypotensive episodes but only 63% of the overall cohort In secondary analyses, the scientists found that weight loss alone did not explain the increased risk, suggesting other mechanisms of action may be at play Below is a Q&A with study senior author Dr

However, the role of endogenous GLP-1 in the attenuation of reward-oriented behavior, and the essential domains of the mesolimbic system mediating these beneficial effects, are largely unknown

& Thompson, S